TRCT
BSTG

Tower Research Capital (TRC)’s Biostage, Inc. Common Stock BSTG Stock Holding History

Tower Research Capital (TRC)’s Portfolio BSTG Stock Details BSTG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3,658
Closed -$1K – 3944
2017
Q1 		$1K Buy
3,658
+3,013
+467% +$1.65K ﹤0.01% 2933
2016
Q4 		$1K Sell
645
-9,528
-94% -$8.49K ﹤0.01% 3737
2016
Q3 		$11K Buy
10,173
+8,076
+385% +$8.69K ﹤0.01% 2032
2016
Q2 		$2K Buy
2,097
+1,186
+130% +$1.91K ﹤0.01% 4069
2016
Q1 		$2K Buy
+911
New +$1.51K ﹤0.01% 3555
2015
Q3 		– Sell
-6,167
Closed -$9K – 5284
2015
Q2 		$9K Buy
6,167
+1,170
+23% +$2.87K ﹤0.01% 2851
2015
Q1 		$16K Sell
4,997
-1,157
-19% -$3.94K ﹤0.01% 2456
2014
Q4 		$20K Buy
+6,154
New +$30.5K ﹤0.01% 1613
2014
Q2 		– Sell
-2,282
Closed -$21K – 5025
2014
Q1 		$21K Buy
+2,282
New +$13.5K ﹤0.01% 1852

Other funds holding BSTG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
GWI
Grace & White Inc Ny, New York $632M AUM 34.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tower Research Capital (TRC)'s BSTG Position: Q2 2017 in Review

Tower Research Capital (TRC) sold out of Biostage, Inc. Common Stock (BSTG) in Q2 2017, closing a stake of 3,658 shares — an estimated $1K sold.

Tower Research Capital (TRC) first reported a position in BSTG in Q1 2014 and held it in 9 quarters. The position peaked at $21K in Q1 2014. 24 funds tracked by Wall St. Rank hold BSTG as of Q2 2017.

  • Tower Research Capital (TRC) reported no remaining Biostage, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 3,658 Biostage, Inc. Common Stock shares in Q2 2017, an estimated $1K.
  • Tower Research Capital (TRC) first reported a position in Biostage, Inc. Common Stock in Q1 2014 and held it in 9 quarters.
  • Tower Research Capital (TRC)'s Biostage, Inc. Common Stock position peaked at $21K in Q1 2014.
  • 24 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q2 2017.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2017, filed 15 Aug 2017.